nps-568 has been researched along with lidocaine in 1 studies
Studies (nps-568) | Trials (nps-568) | Recent Studies (post-2010) (nps-568) | Studies (lidocaine) | Trials (lidocaine) | Recent Studies (post-2010) (lidocaine) |
---|---|---|---|---|---|
162 | 4 | 54 | 26,090 | 5,904 | 5,591 |
Protein | Taxonomy | nps-568 (IC50) | lidocaine (IC50) |
---|---|---|---|
Sodium channel protein type 4 subunit alpha | Homo sapiens (human) | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, SX; Jiang, L; McIntyre, ME; Petrova, E; Tang, L | 1 |
1 other study(ies) available for nps-568 and lidocaine
Article | Year |
---|---|
Calcimimetic acts on enteric neuronal CaSR to reverse cholera toxin-induced intestinal electrolyte secretion.
Topics: Animals; Cell Communication; Cholera Toxin; Colon; Electrolytes; Enteric Nervous System; Evoked Potentials; Female; Intestinal Mucosa; Lidocaine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenethylamines; Propylamines; Receptors, Calcium-Sensing; Tetrodotoxin | 2018 |